EIR Jazz Pharmaceuticals Apr 2014

Sandra Saniga FDA$595.00 - Available Now

FDA investigators audited the Jazz Pharmaceuticals - Palo Alto, CA, United States facility and issued inspectional observation (via FDA 483) on 04 Apr 2014.

Product details

  • Category:
  • Inspection end: 04 Apr 2014
  • Location: Palo Alto, United States
  • FEI: 3005615655
Add To Cart